Carbon Silicon Ventures backs founders turning biology into an engineering discipline. Its portfolio list is dense and specific enough to read its thesis clearly: infrastructure and tools that make biology programmable and scalable, rather than biotech in the traditional therapeutics-pipeline sense.
Portfolio companies include Ansa Biotechnologies (enzymatic DNA synthesis beyond the limits of pho...
San Francisco, United States
New York, United States
Buenos Aires, Argentina
San Diego, United States
United States
Auckland, New Zealand